Skip to main content
OpenTrials

Clinical trial condition

Sphingolipidoses

Explore clinical trials studying Sphingolipidoses. Study availability and eligibility vary by location and protocol.

394 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Sphingolipidoses trial results

Completed

A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE)

NCT00943111

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Tower Hematology Oncology Medical Group Beverly Hills, California, United States
  • UCSF MS Center San Francisco, California, United States
  • University of Colorado Health Science Center - Aurora Aurora, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
View all 34 locations
View Trial Details
Completed

Evaluate the Safety and Exploratory Efficacy of GC1119

NCT01653444

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Asan Medical Center Songpa-gu, Seoul, South Korea
  • Soon Cung Hyang University Hospital Yongsan-gu, Seoul, South Korea
  • Ajou University School of Medicine Yeongtong-gu, Suwon, South Korea
View Trial Details
Completed

Auto-antibodies Prevalence and CD1 Role in Gaucher Disease

NCT02650219

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations
  • Internal Medicine Department, Hôpital Minjoz, Besançon, France
  • Intensive Care Department, Hôpital Pellegrin, Bordeaux, France
  • Internal Medicine Department, Hôpital Beaujon, Clichy, France
  • Internal Medicine and Clinical Immunology Department, CHU, Dijon, France
View Trial Details

Related conditions